Much information has now accumulated which favors the idea that histamine participates in the peripheral sensory function. Kwiatkowski (1) has shown that sensory nerve fibers of the skin is more rich in histamine than the motor nerve fibers and has further demonstrated directly that histamine is liberated after antidromic stimulation of the sensory nerve trunks. Experimental evidences have been supplied by many other workers (2-9), suggesting some relation of histamine to the conduction of stimulus in peripheral sensory nerves. Rosenthal and his associates (10-14) developed the theory that histamine is liberated from the skin by various external stimuli and this substance transmits the stimulus to the sensory nerve endings.
METHODS
Male mice of 15±3 g body weight, fed on the Oriental compressed diet MC5, vegetables, and water, were used throughout the experiments. One group of 12 mice each was used for one dosage level of one kind of a drug. Determination of pain sensitivity and measurement of body temperature were carried out in a room conditioned to 20°-22"'C.
Method of testing analgesic effect. The determination of reaction against pain stimulation was made by Sanuki and Ohno's hot-plate method (17) , which is a modification of the Woolfe Macdonald method (18) , and by the Haffner-Hesse method (19, 20) . The former method is advantageous in that a weaker analgesic effect can be detected than by the latter method but cannot avoid the objection that its reaction largely involves the spinal cord, as in other methods, e.g. the D'Amour and Smith method (21) , that utilize the application of thermal pain stimulus to animals. In contrast, the reflex mechanism on which the latter method is based is thought to involve higher centers (22) .
The temperature of the hot plate was accurately regulated to 55°±0.5°C. The analgesic effect was indicated by the prolongation of the mean reaction time (in seconds), i.e. the time averaged per group, required until the mouse placed on this metal hot plate reacted to thermal stimulation with abnormal movement of the hind paws as described in the original method (17) . The animals used for the experiment showed normal reaction time in the range of 7-13 seconds by preliminary tests.
In the Haffner-Hesse method (19, 20) , the root of the tail and the anal mucosa of the mice were pinched together for 10 seconds with an artery clip with the branches enclosed in a thin rubber tube. The mice selected reacted to this noxious stimulus by promptly biting the clip or by a squeak. The analgesic effect was indicated by the percentage of mice showing insensitivity to this stimulus. Each group of the mice was submitted to these algesimetric determination in the morning every day for one week without injection of any drug. During the next two weeks, the same determination were carried out but followed by a subcutaneous injection of a drug solution on the back, once a day. This means that the pain sensitivity was measured [20] [21] [22] [23] hours after the injection. In order to observe the rate of recovery from analgesia, the same determination was continued for several days after the final injection. Each dose of the drug was administered in 0.1-0.2 c.c. of physiological saline solution and one group injected with the same amount of the saline solution not containing any drug served as the control. Revolving cage test. In order to examine whether the analgesic manifestations detected by the foregoing methods had originated in any central or peripheral motor impairment that is possibly caused by the drugs, this test was devised by utilizing the habit of this animal to play in a revolving cage. After getting the mice used to a box set up with three revolving cages, each provided with openings for the animals to go in and out, by letting the animals play in it for over one week, a group of mice was let into the box all at once and the mean time (in minutes) required until each mouse jumped into the cage was measured. This test was carried out every day, just before the injection of a drug.
Body temperature measurement. The rectal temperature was measured with a thin mercury thermometer specially constructed for mice and the mean value per group was used.
Determination of histamine content in the skin and the rest of the body. A mouse sacrificed by a blow on the head was divided into the skin and other tissues, which were cut into small pieces with scissors. Such tissues of a few groups were used for the Code method (23) for extraction of histamine while the tissues of the remaining groups were treated in the following manner. A sample of the minced tissues was weighed and boiled for 10 minutes with N-hydrochloric acid added in a ratio of 5 c.c./g tissue. This mixture was thoroughly ground in a mortar with fine quartz sand, added with 5 c.(,-./g tissue of distilled water, and again boiled for 3 minutes. After cooling, the mixture was centrifuged, the supernatant was neu tralized with N-sodium hydroxide, and diluted to a known concentration. This was assayed for histamine using an atropinized ileum preparation of a guinea pig. The fact that the contraction of the gut by an active substance was suppressed, in the presence of neoantergan, to the same degree as that by histamine of the same effect, served for identification as histamine. The active principle of the skin extract was all assumed to be histamine. The potassium equivalent of the remainder of tissues was assayed against a standard solution of potassium chloride, from the contraction of the gut in the presence of neoantergan, but its amount corresponded to below 0.1,ug per g tissue of histamine in the activity. The determined value of histamine were expressed as the base.
Estimation of histaminase activity. The remaining one-half of the skin and of the rest of the body tissues used for histamine determination were employed. These were ground up with fine quartz sand and known quantities of 0.9 sodium chloride solution. After frequent shaking for 1 hour, the extract was centrifuged and the histaminase activity of the supernatant was estimated by Kapeller-Adler's volumetric method (24) . Its strength was expressed as P.U. (permanganate unit), 1 P.U. corresponding to the potency destroying 0.46Bg of histamine per hour at 37'C and pH 7.2.
RESULTS

The analgesic effect of repeated daily administration of histamine and histamine liberators
The principal data obtained by the hot-plate method are summarised in Table 1 . The mice administered daily with subcutaneous injection of 0.2-5.0 mg/ 10 g of histamine (dihydrochloride) rapidly showed prolongation of reaction time to thermal stimulus, indicating the development of analgesia. This analgesia reached the maximum 6-8 days after the start of the injection and approximately the same degree of analgesia was maintained throughout the period of further injections. It follows, therefore, that the degree of analgesia depended not on the number of injections but rather on the dose of single injection. The number of days required until the disappearance of analgesia after cessation of the injection seemed to be proportional to the degree of analgesia.
Exactly the same development of analgesia was observed in the case of a repeated injection of 0.5-2 mg/l0 g of sinomenine (hydrochloride)', known as a potent histamine liberator (25) . The only apparent difference in the effect of the two drugs was that the analgesic effect of sinomenine was greater than that of histamine and the maintenance of the effect after cessation of the injections was consequently longer (Fig. 1) .
The histamine-liberating action of quinine (hydrochloride) and irgapyrin5 (an equipart mixture of aminopyrine and butazolidine sodium) is known (26) . These two drugs also caused similar analgesic effect in mice by their repeated injection, though weaker than that of sinomenine. However, no such effect was observed when aminopyrine and butazolidine sodium' were used separately. These two chemicals were found not to liberate histamine by the experiments to be described later. After 8 days' control observation, separate groups were injected daily subcutaneously with 2 mg/ 10 g of histamine dihydrochloride (1), 2 mg/ 10 g of sinomenine hydrochloride (2) and 0.1 c.c./10 g of 0.900' saline solution (4) for 14 days. Another group (3) received alternate injection of 2 mg/10g of histamine and 0.5 mg/10g of sinomenine for the same period. In groups 1 and 2 marked analgesic effect was indicated, lasting for several days even after cessation of the treatment, while in 3 and 4 no such effect was observed. The extremely interesting fact is that an alternate daily administration of 2 mg/10 g of histamine and 0.5 mg,/ 10 g of sinomenine, doses which cause about the same degree of the effect, failed to show any analgesic effect by the mutual antagonism of these two drugs. In this case, the results were almost comparable to that of the control injected with 0.1 c.c./10 g of 0.9~ sodium chloride solution (Fig. 1) .
Subcutaneous injections of 0.05 mg/ 10 g of neoantergan and 0.5 mg/ 10 g of histamine or 0.5 mg/10 g of sinomenine, were given concurrently but separately on the back. The degree of analgesia developed by such injections repeated daily seemed to show that neoantergan weaken the effect of sinomenine somewhat but indicated that there was no noticeable influence on that of histamine. The repeated administration of neoantergan in the dosage here employed did not cause analgesia although this dose is enough to antagonize other pharmacological actions of histamine (27) . Repeated injection of 0.1 mg/10 g of cortisone (acetate) caused a slight degree of analgesia.
Concurrent use of 0.5 mg/ 10 g of sinomenine and 0.1 mg/ l0 g of cortisone for 1 week resulted in development of a far stronger analgesia than by the use of sinomenine alone. This degree of analgesia was maintained even with the dosage of cortisone decreased to 0.025 mg/ 10 g. In these groups, however, motor impairment was detected by the evidence of prolongation of reaction time in the revolving cage test. But in the other foregoing groups the prolongation of mean reaction time in the hot-plate method did not embody this kind of motor impairment (Fig. 2 ).
It was difficult to detect weak analgesia by the method of Haffner and Hesse but the development of comparatively marked analgesia in the foregoing experiments was confirmed also by this method (Fig. 1) . The results are summarized in Table 2 .
Subcutaneous injection of 0.2-2 mg/l0 g of histamine caused a fall of body temperature which reached the maximum 30 minutes after the injection. This body temperature lowering effect became rapidly weaker by the daily repetition of the injection and the animal became completely insensitive to the same dose of histamine after 7-12 injections (Fig. 3) . However, the animals desensitized to a smaller dose of histamine showed a fall in body temperature by a larger dose (2 mg/10 g) of histamine, the degree of fall being smaller than that in mice without prior treatment. Subcutaneous injection of the same dose of sinomenine caused a more marked fall in body temperature than in the case of histamine but the maximum fall in this case occurred 60 minutes after the injection. Pronounced desensitization also developed by consecutive daily injection of sinomenine, though more incomplete than in the case of histamine (Fig. 3) . Such desensitization observed with histamine and sinomenine could be gradually reversed by cessation of the injections.
An alternate repeated administration of histamine and sinomenine failed to cause almost any desensitization inherent in each drug. This observation indicates that the desensitizing action of histamine and histamine liberators are mutually antagonistic, as was the case in the afore-mentioned analgesic effect (Fig. 3) .
Administration of 0.5 mg/10g of quinine or 0.3 mg/10g of irgapyrin caused a body temperature fall milder than that caused by 0.5 mg 10 g of sinomenine and their repeated administration indicated an incomplete desensitization.
The administration of 0.05 mg/ 10 g of neoantergan slightly decreased the body temperature fall caused by the concurrently injected histamine and sinomenine but did not modify the occurrence of desensitization by these two drugs.
Initial subcutaneous injection of 0.1-0.5 mg/10 g of cortisone caused very gradual but comparatively marked fall in the body temperature, which reached the minimum 240-300 minutes after the injection. This action weakened as a result of repeated administration and the recovery tended to become shorter, the maximum fall of temperature occurring 60-120 minutes after the injection. However, a concurrent administration of 0.1 mg/ 10 g of cortisone did not affect the maximum fall of temperature caused by sinomenine but there was a tendency for the desensitization to occur earlier.
In mice given repeated administration of sinomenine for 11-13 days an injection of histamine caused a far more drastic fall of body temperature than in the case of untreated animals. Even in the mice administered with cortisone alone, there was a tendency, though slight, for the fortification of histamine action. In the group given injections of sinomenine and cortisone at the same time, the action of histamine was found to be more strengthened than in the group administered with sinomenine alone, as observed by the longer duration of the hypothermic effect.
In the mice desensitized against quinine and irgapyrin, there was a tendency for increased sensitivity to histamine, though statistically insignificant.
Histamine content in the skin and the rest of the body
In order to consider the mechanism of the analgesia produced by histamine and histamine liberators and of the desensitization in the body temperature fall, the variation of tissue histamine content of the skin and the rest of the body during such treatment was examined. The histamine contents in the skin and the remaining tissues of normal mice are respectively 63.8±2.6 and 8.1 -r 0.4 ug' g by the Code's extraction method, and 74.0-+-1.8 and 6.5±0.2 , egg wet tissue respectively by the simplified method of hydrolysis with hydrochloric acid. The histamine contents in these tissues were measured on the next day of the 14th, i.e. the final injection, when the analgesia in all the groups became sufficiently constant, and 18 days thereafter, when analgesia has apparently disappeared completely. The histamine values were then compared with the normal value obtained by the same extraction method. Table 3 summarizes these results. Repeated injection of 0.5 and 5 mg/10 g of histamine caused a marked increase in the skin histamine and the degree of its increase was proportional to the size of each dose used. This increase of histamine content declined gradually after completion of the injection but the recovery was not complete even after 18 days. FIG. 4 . Changes in histamine content of the skin of mice at indicated periods after repeated daily subcutaneous injection of histamine and sinomenine. Curve 1 shows the changes by 0.5 mg/ 10 g, and Curve 2 for 2 mg/ 10 g daily injection of histamine dihydrochloride. Curves 3 and 4 denote changes by sinomenine hydrochloride in a daily dose of 0.5 and 2 mg/ 10 g, respectively. Curves 1 and 3 by Code's method, Curves 2 and 4 by the simplified method of acid hydrolysis described in the text, for histamine extraction.
Repeated injection of 0.5 and 2 mg/10 g of sinomenine showed a conspicuous decrease of skin histamine. This decrease did not recover 18 days after the termination of the injection and even some further decrease was indicated on injection of 2 mg/ 10 g of sinomenine. In any of the cases of such injection, the maximum analgesia was acquired mostly by about seven injections and later continuation of the injection did not seem to increase the degree of analgesia. In this connection, the skin histamine content after seven injections of histamine or sinomenine was measured in another group of mice and the value obtained was found to be fairly close to that after 14 injections (Fig. 4) . The histamine content in the whole tissue except skin showed a rate of variation approximately in parallel with that of the skin, though the amount per gram of the former tissue was smaller.
In the group of mice in which analgesia did not develop by an alternate injection of histamine and sinomenine, there was an increase of histamine in both tissues, especially marked in the skin. Since this increase was maintained even 18 days after the final injection, this is probably not the simple accumulation of histamine injected or liberated and is presumably related to the fact that the skin around the site of injection on the back of these mice was thickened and became friable and histologically revealed a marked inflammatory changes. It is well known that histamine increases in inflamed tissues (28) .
Repeated administration of quinine or irgapyrin resulted in a distinct decrease of histamine content in both tissues and the degree of such decrease seemed to be approximately proportional to the size of analgesic effect manifested by these drugs, as compared with sinomenine. Both aminopyrine and butazolidine sodium failed to cause any significant change of histamine content in these tissues.
Concurrent use of 0.05 mg/10 g of neoantergan appeared to diminish the rate of increase of skin histamine by histamine injection and of decrease of it by sinomenine but the differences were not statistically significant (0.5>P>0.4 and 0.3>P>0.2).
Cortisone itself did not give any marked effect on the histamine content in both the skin and the rest of the body but decreased the rate of skin histamine depletion by sinomenine, from P<0.001 to 0.1>P>0.05. 4 . Histaminase activity of the skin and the rest of the body The skin of normal mice showed a fairly high histaminase activity not markedly differing from that in the remaining tissues. This differs from the extremely low activity of skin histaminase in the dog (29) .
Repeated injection of histamine resulted in an increase of skin histaminase activity while a similar administration of sinomenine, quinine, or irgapyrin caused a decrease of it, appro ximately in parallel with the decrease of skin histamine. This fact appears to suggest that the change of skin histaminase is dependent on the variation of histamine content.
In this respect, it is interesting that the concurrent use of cortisone, which suppresses histamine release, with sinomenine caused a more marked decrease of histaminase activity than in the case of sinomenine alone. After the alternate injection of histamine and sinomenine the skin histaminase activity was markedly decreased. It does not seem to be an usual change because of the difficulty of its recovery after cessation of the injection and the increase of hista mine content in such a case. This may be due to injury of tissue cells.
The histaminase content in the rest of the body showed increase, irrespective of the increase or decrease of histamine content. It is probably necessary to make considerations different from that for the skin since this sample of the rest of the body contains different tissues and because the change in histamine content is much smaller than that in the skin in absolute value (Table 4) . TABLE 4 . Effects of repeated daily injection of histamine, sinomenine, and some other drugs on the histaminase activity in the skin and the rest of the body of mice.
DISCUSSION
The present series of experiments confirmed the fact reported by Jacob et al. (15, 16 ) that repeated daily administration of histamine causes analgesia. Further, repeated injection of sinomenine, known as a histamine liberator (25) , was found to develop similar analgesia. These analgesia were proved by the revolving cage test to be not a disguise of the motor impairment due to the general toxicity of these drugs.
A similar analgesia was also observed after repeated injection of quinine or irgapyrin, but not by the individual administration of aminopyrine or butazolidine sodium, the components of irgapyrin. The degree of analgesia produced by sinomenine, quinine, and irgapyrin was in parallel with the decrease of skin histamine in the mouse under these conditions. Liberation of histamine was not detected in the case of aminopyrine and butazolidine sodium which could not cause this kind of analgesia. Such facts suggest that analgesia caused by daily injection of sinomenine is related to its effect of causing depletion of tissue histamine.
Opinions vary as to the effect of cortisone on histamine metabolism. Schayer et al. (30, 31) suggested that cortisone had the effect of preventing new binding of histamine in rat skin The results of the present series of experiments clearly indicate that the concurrent use of cortisone lessens the rate of depletion of the tissue histamine by sinomenine. The increase in the analgesic effect of sinomenine under the concurrent use of cortisone should be given attention with regard to another observation in the present experiments that cortisone itself possesses analgesic effect in spite of the fact that it does not cause histamine release, because the suppression of histamine release from the skin is of the same meaning as exhaustion of available histamine for actual release if histamine is taken as the chemical mediator necessary for the appearance of pain sensation.
The fall of body temperature by histamine and sinomenine is thought to be due chiefly to the dilatation of cutaneous vessels by histamine (35) , injected in one case and liberated in the other. The feature of desensitization of the two drugs observed in the hypothermic effect suggests that its mechanism is similar to that of analgesia caused by the same treatment .
The desensitization to these drugs occurred even under the concurrent use of antihistamines but desensitization of sinomenine was accelerated by the use of cortisone at the same time.
These facts also present evidences for the support of the foregoing idea.
